Evidence map›Paper›PMID 29507865›Full record

ReviewJournal of immunology research2018

Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?

Luca Parisi, Elisabetta Gini, Denisa Baci, Marco Tremolati, Matteo Fanuli, Barbara Bassani, Giampietro Farronato, Antonino Bruno, Lorenzo Mortara

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04375176 (Study of Immune-mediated Mechanisms in Patients Tested Positive for SARS-CoV-2), which is not on this map. Cited by 279 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
279citing papers in PubMed, 1 pooled it
19.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04375176 unknown statusnot on this mapstarted 2020, after this paper: background citation

Study of Immune-mediated Mechanisms in Patients Tested Positive for SARS-CoV-2: Phenotypic and Functional Analysis of Monocytes and NK Cells in the Blood of Subjects Affected by Covid 19

TypeobservationalSponsorUniversità degli Studi dell'InsubriaRan2020 to 2020Enrolled150ConditionsCOVID-19, Severe Acute Respiratory Syndrome Coronavirus 2, ImmunomodulationArmsStudy of immune-mediated mechanisms in patients tested positive for SARS-CoV-2
3 · Its place in the literature

Who cites it

279 citing papers in PubMed, 1 synthesis or guideline pooled it, 518 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. MPRO3 Regulates Macrophage Polarization and OsteoclastogenesisJournal of microbiology and biotechnology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Macrophage states and polarization duringFrontiers in cellular and infection microbiology · 2026
    Review
  15. Intracellular survival ofVirulence · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

219 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Luca ParisiDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.ORCID 0000-0002-3511-7992
Elisabetta GiniImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.ORCID 0000-0003-3543-8777
Denisa BaciScientific and Technologic Park, IRCCS MultiMedica, Milan, Italy.
Marco TremolatiDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Matteo FanuliDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Barbara BassaniImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.ORCID 0000-0002-8002-1607
Giampietro FarronatoDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Antonino BrunoScientific and Technologic Park, IRCCS MultiMedica, Milan, Italy.ORCID 0000-0002-4790-0861
Lorenzo MortaraImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
University of Milan · ITUniversity of Insubria · ITMultiMedica · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are key cellular components of the innate immunity, acting as the main player in the first-line defence against the pathogens and modulating homeostatic and inflammatory responses. Plasticity is a major feature of macrophages resulting in extreme heterogeneity both in normal and in pathological conditions. Macrophages are not homogenous, and they are generally categorized into two broad but distinct subsets as either classically activated (M1) or alternatively activated (M2). However, macrophages represent a continuum of highly plastic effector cells, resembling a spectrum of diverse phenotype states. Induction of specific macrophage functions is closely related to the surrounding environment that acts as a relevant orchestrator of macrophage functions. This phenomenon, termed polarization, results from cell/cell, cell/molecule interaction, governing macrophage functionality within the hosting tissues. Here, we summarized relevant cellular and molecular mechanisms driving macrophage polarization in "distant" pathological conditions, such as cancer, type 2 diabetes, atherosclerosis, and periodontitis that share macrophage-driven inflammation as a key feature, playing their dual role as killers (M1-like) and/or builders (M2-like). We also dissect the physio/pathological consequences related to macrophage polarization within selected chronic inflammatory diseases, placing polarized macrophages as a relevant hallmark, putative biomarkers, and possible target for prevention/therapy.

Indexed as

AnimalsCell DifferentiationChronic DiseaseCytokinesHumansImmune System DiseasesInflammationMacrophagesTh1 CellsTh2 CellsCytokines

Identifiers

PMID29507865
PMCPMC5821995
OpenAlexW2783643850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.